The next wave of cellular immunotherapies in pancreatic cancer

por Yeo, Dannel, Giardina, Caroline, Saxena, Payal, Rasko, John E.J.
Publicado 2022

Anti-Mesothelin CAR T cell therapy for malignant mesothelioma

por Castelletti, Laura, Yeo, Dannel, van Zandwijk, Nico, Rasko, John E. J.
Publicado 2021

Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma

por Yeo, Dannel, Castelletti, Laura, van Zandwijk, Nico, Rasko, John E. J.
Publicado 2021

FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

por Yeo, Dannel, He, Hong, Patel, Oneel, Lowy, Andrew M., Baldwin, Graham S., Nikfarjam, Mehrdad
Publicado 2016

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

por Yeo, Dannel, Bastian, Althea, Strauss, Heidi, Saxena, Payal, Grimison, Peter, Rasko, John E. J.
Publicado 2022

Mapping oncogenic protein interactions for precision medicine

por Sharifi Tabar, Mehdi, Francis, Habib, Yeo, Dannel, Bailey, Charles G., Rasko, John E. J.
Publicado 2022

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging

por Yeo, Dannel, Kao, Steven, Gupta, Ruta, Wahlroos, Sara, Bastian, Althea, Strauss, Heidi, Klemm, Vera, Shrestha, Prajwol, Ramirez, Arturo B., Costandy, Lillian, Huston, Ryan, Gardner, Brady S., Grimison, Peter, Clark, Jonathan R., Rasko, John E. J.
Publicado 2023